✦ LIBER ✦

Dabigatran etexilate: Another Double-Edged Drug?

✍ Scribed by Juan C. Laguna, Marta Alegret

Book ID: 118797352
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 243 KB
Volume: 26
Category: Article
ISSN: 0920-3206
DOI: 10.1007/s10557-012-6416-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dabigatran etexilate/various other drugs

✍ Liu, Yuyuan; Liu, Hong; Tu, Xiwen; Peng, Youming; Liu, Fuyou; Zhang, Fan; Guo, C 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 129 KB

Autophagy and metastasis: another double

Autophagy and metastasis: another double-edged sword

✍ Candia M Kenific; Andrew Thorburn; Jayanta Debnath 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Dosing of dabigatran etexilate in relati

Dosing of dabigatran etexilate in relation to renal function and drug interactions at a tertiary hospital

✍ Chin, P. K. L.; Vella-Brincat, J. W. A.; Walker, S. L.; Barclay, M. L.; Begg, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB

Realistic Assessment of Drug-induced Adv

Realistic Assessment of Drug-induced Adverse Events: A Double-edged Sword

✍ Victor L. Serebruany 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Nitric Oxide and Apoptosis: Another Para

Nitric Oxide and Apoptosis: Another Paradigm for the Double-Edged Role of Nitric Oxide

✍ Stefanie Dimmeler; Andreas M. Zeiher 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Dabigatran etexilate versus enoxaparin f

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

✍ Bengt I Eriksson; Ola E Dahl; Nadia Rosencher; Andreas A Kurth; C Niek van Dijk; 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 130 KB